A review of data collected on 117,000 claims and lawsuits by the Physician Insurers Association of American (PIAA) reveals that medication errors are the second most frequent reason for claims against physicians and result, cumulatively, in the second highest indemnity paid, following faulty diagnosis and evaluation. According to a National Center for Health Statistics report in 1992, medications are ordered or provided at more than 19 million patient visits a year to an ophthalmologist’s office. With such a large volume of prescribing activity, it is not surprising that claims related to drug prescribing constitute a significant proportion of all claims for malpractice damages in ophthalmology.
This chapter aims to help practicing ophthalmologists avoid malpractice litigation related to prescribing and using drugs in ophthalmic care. A series of topics pertinent to prescribing and using drugs in a routine ophthalmic practice are presented in a question and answer format.
KeywordsDiabetic Macular Edema Retinal Vein Occlusion Generic Substitution Malpractice Claim Medical Marijuana
Unable to display preview. Download preview PDF.
- 1.Medication Error Study. Washington, DC: Physician Insurers Association of America; June 1993.Google Scholar
- 10.Bettman JW, Monica ML. Nonmedical issues in claims against ophthalmologist. OMIC pub-lication archives. Digest, Winter 1994. Available at: http://www.omic.com/resources/risk_ man/deskref/medicaloffice/general/8.cfm.
- 11.Abood RR. Pharmacy Practice and the Law, 4th ed. Boston: Jones and Bartlett Publishers; 2005:101-144.Google Scholar
- 16.Demorest BD. Minimize the risks of patient co-management. OMIC publication archives. Digest, Spring 1995. Available at: http://www.omic.com/resources/risk_man/desref/coman-agement/1.cfm.
- 18.Craven ER, Moran EC. Medical implications of using off-label drugs and devices. OMIC publication archives. Digest, Winter, 1996. Available at: http://www.omic.com/resources/ risk_man/deskred/clinical/28.cfm.
- 19.Abood RR. Pharmacy Practice and the Law, 4th ed. Boston: Jones and Bartlett Publishers; 2005:145-183.Google Scholar
- 20.Apt L, Gaffney WL. Toxic effects of topical eye medications in infants and children. In: Tasman W, Jaeger EA, eds. Duane’s Clinical Ophthalmology. Philadelphia: Lippincott Williams & Wilkins; 2002;43:133342-133752.Google Scholar
- 24.Iezzoni LI. Discharge blindly. Agency for Healthcare Research and Quality (AHRQ) Web Morbidity and Mortality (Web M&M) Rounds on the Web. Case and Commentary. December 2005. Available at: http://www.webmm.ahrq.gov/case.aspx?caseID=111.
- 26.Deutsche RA. Discuss potential side effects of eye drops. OMIC publication archives. Argus, January 1992. Available at: http://www.omic.com/resources/risk_man/deskred/clinical/9.cfm.